Department of Neurosurgery, Tongji hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095# Jiefang Avenue, Wuhan, 430030, Hubei, China.
BMC Neurol. 2021 May 11;21(1):190. doi: 10.1186/s12883-021-02227-3.
The aim of this study was to evaluate the effect of surgical resection and stereotactic biopsy on the complication rate, progression-free survival (PFS) and overall survival (OS) of 70 patients diagnosed at a single institution with primary central nervous system lymphoma (PCNSL) and to explore the predictors of selection for resection and the prognostic factors of PCNSL.
A retrospective analysis was performed of 70 patients with PCNSL that was diagnosed by surgical resection or stereotactic brain biopsy in our department from January 2013 to May 2019. We divided the patients into two groups: a resection group (n = 28) and a stereotactic biopsy group (n = 42). Data on clinical characteristics, imaging findings, complication rates, PFS and OS were retrospectively reviewed and compared between these two groups. We also analysed the predictors of selection for resection and prognostic factors of PCNSL by multivariate analysis.
The median age was 53.3 ± 14.3 years, and there was a male predominance with a sex ratio of 1.33:1. The most common clinical manifestation was a headache. The complication rate in the resection group was 10.7% versus 7.1% in the stereotactic biopsy group, and there was no statistically significant difference. The rate of improvement in symptoms of the resection group was significantly higher than that of the stereotactic biopsy group. Multivariable analysis identified a single tumour and not involving deep structures as predictors of selection for resection. With a median follow-up of 30 months (range 1-110), the mean OS and PFS of all patients were 16.1 months and 6.2 months, respectively. Patients who underwent surgical resection had a mean OS of 23.4 months and PFS of 8.6 months versus 11.2 months and 4.6 months for those who had a brain biopsy performed. In addition, multivariable analysis showed that not involving deep structures and resection were favourable prognostic factors for PCNSL.
The outcomes of patients with PCNSL treated in our cohort are still poor. In our series, surgical resection might play a role in significantly improving OS and PFS compared with stereotactic biopsy in a subset of patients. The type of surgery and tumour location are prognostic factors for PCNSL.
本研究旨在评估在单家机构中对 70 例原发性中枢神经系统淋巴瘤(PCNSL)患者进行手术切除和立体定向活检对并发症发生率、无进展生存期(PFS)和总生存期(OS)的影响,并探讨选择手术切除的预测因素和 PCNSL 的预后因素。
回顾性分析了 2013 年 1 月至 2019 年 5 月在我院行手术切除或立体定向脑活检诊断为 PCNSL 的 70 例患者。将患者分为两组:切除组(n=28)和立体定向活检组(n=42)。回顾性分析比较两组患者的临床特征、影像学表现、并发症发生率、PFS 和 OS。还通过多变量分析分析了选择手术切除的预测因素和 PCNSL 的预后因素。
中位年龄为 53.3±14.3 岁,男性居多,男女比例为 1.33:1。最常见的临床表现是头痛。切除组的并发症发生率为 10.7%,立体定向活检组为 7.1%,差异无统计学意义。切除组症状改善率明显高于立体定向活检组。多变量分析显示,单个肿瘤和不涉及深部结构是选择手术切除的预测因素。中位随访 30 个月(范围 1-110),所有患者的平均 OS 和 PFS 分别为 16.1 个月和 6.2 个月。接受手术切除的患者的平均 OS 为 23.4 个月,PFS 为 8.6 个月,而接受立体定向活检的患者的平均 OS 为 11.2 个月,PFS 为 4.6 个月。此外,多变量分析显示,不涉及深部结构和切除是 PCNSL 的有利预后因素。
本队列中 PCNSL 患者的预后仍然较差。在本系列中,与立体定向活检相比,手术切除可能在某些患者中显著改善 OS 和 PFS。手术类型和肿瘤位置是 PCNSL 的预后因素。